Kiruthi Palaniswamy

Kiruthi is the Vice President of Medical Affairs. She brings 20+ years of scientific leadership and medical affairs experience across large-market and rare diseases. She heads the development of the medical strategy and plan, integrating the voice of the medical community and the patient across Kezar’s development platforms. Kiruthi also oversees collaborations with key patient advocacy organizations working in rare diseases. She has developed and implemented integrated medical plans in support of pipeline, pre-launch, and marketed products to advance evidence-based care and ultimately impact patient outcomes. Prior to joining Kezar, Kiruthi held positions of increasing responsibility at Sanofi-Aventis, Galderma Laboratories, and Corcept Therapeutics.